RICHLAND, Wash.--(BUSINESS WIRE)--July 6, 2006--IsoRay Medical, Inc.'s collaboration with Idaho National Laboratory took a major step June 27 when testing began to demonstrate production of...
RICHLAND, Wash.--(BUSINESS WIRE)--June 28, 2006--IsoRay Medical, Inc. has named Eric Knipfer Southeast Area Director as the company continues to expand its relationships with top physicians,...
IsoRay Announces Listing in Standard & Poor's Daily News
IsoRay, Inc. ("IsoRay") (OTCBB:ISRY message board, news, dd, quote), a medical technology company focusing on innovative treatment for...
InterCommunity Cancer Center in Leesburg Introduces IsoRay Medical, Inc.'s Cesium-131 Medical Isotope for Treating Prostate Cancer; First Implant in Florida Using Breakthrough Treatment Scheduled...
#7: ISRY News IsoRay, Inc. Announces North American Licensing Agreement Letter of Intent with IBt s.a. for Use of Polymer Seed Technology with Cesium-131
RICHLAND, Wash.--(BUSINESS WIRE)--Jan. 3, 2006--IsoRay, Inc. (OTCBB:ISRY) with its subsidiary IsoRay Medical, Inc., and IBt s.a. (EURONEXT:IBTB) announce that they have signed a letter of intent...
POCATELLO, Idaho--(BUSINESS WIRE)--Dec. 14, 2005--Five organizations gathered today to announce the signing of collaboration and partnership agreements for testing production of a breakthrough...
#5: ISRY News Durham Regional Hospital Introduces New Prostate Cancer Treatment from IsoRay Medical, Inc.; First in Southeast to Offer Treatment Breakthrough
DURHAM, N.C.--(BUSINESS WIRE)--Nov. 30, 2005--IsoRay Medical, Inc.:
WHAT:
-- Durham Regional Hospital is the first medical facility in
the Southeast to offer patients a...
#4: ISRY News Durham Regional Hospital Introduces Promising Cesium-131 Isotope for Treating Prostate Cancer; First Implant in the Southeast Using IsoRay Medical's Breakthrough Treatment Scheduled for November 30
DURHAM, N.C.--(BUSINESS WIRE)--Nov. 28, 2005--A breakthrough treatment for prostate cancer is now available for patients in the region at Durham Regional Hospital, representing the first major...
RICHLAND, Wash.--(BUSINESS WIRE)--Nov. 3, 2005--IsoRay, Inc. (OTCBB:ISRY), today announced that its application for quotations on the OTC Bulletin Board has been approved. Effective at the open of...
RICHLAND, Wash.--(BUSINESS WIRE)--Nov. 3, 2005--IsoRay Medical, Inc. the sole manufacturer and distributor of Cesium-131 isotope seeds used in brachytherapy for the treatment of prostate cancer,...
--(BUSINESS WIRE)-- WHAT: IsoRay Medical, Inc., a subsidiary of IsoRay, Inc., (PINK SHEETS:ISRY), is producing a powerful new kind of radioactive, cancer-destroying isotope seed made...
